The new frontier of hepatitis C virus (HCV)-mismatched heart and lung transplantation.
作者信息
Solli Piergiorgio, Dolci Giampiero, Ranieri V Marco
机构信息
Department of Cardio-Thoracic Surgery, Policlinico S.Orsola Malpighi University Hospital, Bologna, Italy.
Anesthesia & Intensive Care Medicine, Alma Mater Studiorum University of Bologna, Policlinico di S.Orsola, Bologna, Italy.
出版信息
Ann Transl Med. 2019 Dec;7(Suppl 8):S279. doi: 10.21037/atm.2019.11.123.
Abstract
摘要
相似文献
1
The new frontier of hepatitis C virus (HCV)-mismatched heart and lung transplantation.丙型肝炎病毒（HCV）不匹配的心肺移植新领域。
Ann Transl Med. 2019 Dec;7(Suppl 8):S279. doi: 10.21037/atm.2019.11.123.
2
Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients.HCV 感染供体的心肺移植到未感染受者。
N Engl J Med. 2019 Apr 25;380(17):1606-1617. doi: 10.1056/NEJMoa1812406. Epub 2019 Apr 3.
3
Virology and pathogenesis of hepatitis C virus recurrence.丙型肝炎病毒复发的病毒学与发病机制。
Liver Transpl. 2008 Oct;14 Suppl 2:S27-35. doi: 10.1002/lt.21644.
4
Serological pattern of hepatitis C virus recurrence after liver transplantation.肝移植后丙型肝炎病毒复发的血清学模式。
J Hepatol. 1996 Jan;24(1):15-20. doi: 10.1016/s0168-8278(96)80180-2.
5
Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial.丙型肝炎病毒血症供肺者肺移植中病毒传播的预防：一项开放标签、单中心、初步试验。
Lancet Respir Med. 2020 Feb;8(2):192-201. doi: 10.1016/S2213-2600(19)30268-1. Epub 2019 Oct 9.
6
Heart Transplantation for Hepatitis C Virus Non-Viremic Recipients From Hepatitis C Virus Viremic Donors.丙型肝炎病毒血症供者向丙型肝炎病毒非血症受者进行心脏移植。
Cardiol Rev. 2019 Jul/Aug;27(4):179-181. doi: 10.1097/CRD.0000000000000255.
7
Transmission of hepatitis C virus by organ transplantation in the United Kingdom.英国丙型肝炎病毒通过器官移植传播的情况。
J Hepatol. 1994 Jun;20(6):768-72. doi: 10.1016/s0168-8278(05)80148-5.
8
Hepatitis C virus and nonliver solid organ transplantation.丙型肝炎病毒与非肝脏实体器官移植。
Transplantation. 2013 Mar 27;95(6):779-86. doi: 10.1097/TP.0b013e318273fec4.
9
Impact of hepatitis G virus co-infection on the course of hepatitis C virus infection before and after liver transplantation.庚型肝炎病毒合并感染对肝移植前后丙型肝炎病毒感染病程的影响。
J Hepatol. 1998 Dec;29(6):893-900. doi: 10.1016/s0168-8278(98)80116-5.
10
Effects of preoperative hepatitis B virus infection, hepatitis C virus infection, and coinfection on the development of new-onset diabetes after kidney transplantation.术前乙型肝炎病毒感染、丙型肝炎病毒感染和合并感染对肾移植后新发糖尿病的影响。
J Diabetes. 2019 May;11(5):370-378. doi: 10.1111/1753-0407.12853. Epub 2018 Oct 14.
引用本文的文献
1
Trends in use and three-year outcomes of hepatitis C virus-viremic donor lung transplants for hepatitis C virus-seronegative recipients.丙型肝炎病毒感染者接受丙型肝炎病毒血症供体肺移植的使用趋势和三年结局。
J Thorac Cardiovasc Surg. 2023 Apr;165(4):1587-1595.e2. doi: 10.1016/j.jtcvs.2022.08.019. Epub 2022 Sep 7.
2
Efficacy and safety of sofosbuvir-containing regimens in patients with chronic hepatitis C virus infection after liver transplantation: a meta-analysis.含索磷布韦方案治疗肝移植后慢性丙型肝炎病毒感染患者的疗效与安全性：一项荟萃分析
Ann Transl Med. 2020 May;8(10):648. doi: 10.21037/atm-20-3074.
3
A safety and efficacy analysis of direct-antiviral therapy in patients with chronic hepatitis C after renal transplantation.肾移植后慢性丙型肝炎患者直接抗病毒治疗的安全性和疗效分析。
Transl Androl Urol. 2020 Apr;9(2):583-590. doi: 10.21037/tau.2020.01.05.
本文引用的文献
1
Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial.丙型肝炎病毒血症供肺者肺移植中病毒传播的预防：一项开放标签、单中心、初步试验。
Lancet Respir Med. 2020 Feb;8(2):192-201. doi: 10.1016/S2213-2600(19)30268-1. Epub 2019 Oct 9.
2
Outcomes of marginal donors for lung transplantation after ex vivo lung perfusion: A systematic review and meta-analysis.体外肺灌注后边缘供体肺移植的结果：系统评价和荟萃分析。
J Thorac Cardiovasc Surg. 2020 Feb;159(2):720-730.e6. doi: 10.1016/j.jtcvs.2019.07.087. Epub 2019 Aug 25.
3
Potential for donation after circulatory death heart transplantation in the United States: Retrospective analysis of a limited UNOS dataset.美国循环死亡后心脏移植的捐赠潜力：对有限 UNOS 数据集的回顾性分析。
Am J Transplant. 2020 Feb;20(2):525-529. doi: 10.1111/ajt.15597. Epub 2019 Oct 28.
4
HIV and Solid Organ Transplantation: Where Are we Now.艾滋病毒与实体器官移植：我们现在在哪里。
Curr HIV/AIDS Rep. 2019 Oct;16(5):404-413. doi: 10.1007/s11904-019-00460-7.
5
Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients.HCV 感染供体的心肺移植到未感染受者。
N Engl J Med. 2019 Apr 25;380(17):1606-1617. doi: 10.1056/NEJMoa1812406. Epub 2019 Apr 3.
6
Transplanting hepatitis C virus-infected hearts into uninfected recipients: A single-arm trial.将丙型肝炎病毒感染的心脏移植到未感染的受者体内：一项单臂试验。
Am J Transplant. 2019 Sep;19(9):2533-2542. doi: 10.1111/ajt.15311. Epub 2019 Mar 20.
7
Inactivating hepatitis C virus in donor lungs using light therapies during normothermic ex vivo lung perfusion.在常温离体肺灌注过程中使用光照疗法使供体肺中的丙型肝炎病毒失活。
Nat Commun. 2019 Jan 29;10(1):481. doi: 10.1038/s41467-018-08261-z.
8
A Perspective Regarding the Current State of the Opioid Epidemic.关于阿片类药物流行现状的观点
JAMA Netw Open. 2019 Jan 4;2(1):e187104. doi: 10.1001/jamanetworkopen.2018.7104.
9
Twelve-Month Outcomes After Transplant of Hepatitis C-Infected Kidneys Into Uninfected Recipients: A Single-Group Trial.感染 HCV 的供肾移植至未感染受者后 12 个月的结果：单组试验。
Ann Intern Med. 2018 Sep 4;169(5):273-281. doi: 10.7326/M18-0749. Epub 2018 Aug 7.
10
Early outcomes using hepatitis C-positive donors for cardiac transplantation in the era of effective direct-acting anti-viral therapies.在有效直接作用抗病毒治疗时代使用丙型肝炎阳性供体进行心脏移植的早期结果。
J Heart Lung Transplant. 2018 Jun;37(6):763-769. doi: 10.1016/j.healun.2018.01.1293. Epub 2018 Jan 31.
Zotero 插件